Gemmocomplexe I
Gemmocomplexe I, licence 80051544: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Laboratoire Schmidt-Nagel Inc.
- NPN or DIN-HM
- 80051544
- Status
- Active licence
- Licence date
- 9 June 2014
- Revision date
- Not provided
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
- Conditions légales
Juniperus communis L.: L'étiquetage doit comporter un avertissement recommandant de ne pas utiliser en cas d'insuffisance rénale et un avertissement recommandant de ne pas utiliser de manière prolongée (maximum 6 semaines)
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Juglans regia Source : Bourgeons Extract : Matériel brut frais Extraction ratio : 1:20 Dry plant equivalent : 0.083 mg | 0.00166 mL | Not calculated |
| Juniperus communis Source : Jeunes pousses Extract : Matériel brut frais Extraction ratio : 1:20 Dry plant equivalent : 0.083 mg | 0.00166 mL | Not calculated |
| Rosmarinus officinalis Source : Jeunes pousses Extract : Matériel brut frais Extraction ratio : 1:20 Dry plant equivalent : 0.083 mg | 0.00166 mL | Not calculated |
Non-medicinal ingredients
Alcool, Eau purifiée, Glycine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18.0 Année(s) | minimum: 10.0 Goutte(s) ; maximum: 30.0 Goutte(s) | minimum: 1.0 Jour(s) ; maximum: 3.0 Jour(s) |
Uses authorised in Canada
Remède de gemmothérapie.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Veuillez consulter un praticien de soins de santé si les symptômes persistent ou s'aggravent. Veuillez consulter un praticien de soins de santé avant d'en faire usage si vous êtes enceinte ou si vous allaitez.
Source
Official Health Canada record, licence 80051544
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.